Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | ACLY | P53396 | 2/20 | 0.30 |
| ▸ | KDM6B | O15054 | 1/20 | 0.30 |
| ▸ | KDM5C | P41229 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.30 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27076088 | 0.98 | ALDH1A1 (0.37) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL28452924 | 0.98 | ALDH1A1 (0.37) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL9241914 | 0.96 | EGLN1 (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL1989298 | 0.96 | ALDH1A1 (0.39) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL119741 | 0.91 | EGLN1 (0.39) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| Succinic Acid SCHEMBL8002651 | 0.91 | EGLN1 (0.39) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL10410369 | 0.89 | TSHR (0.41) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| Succinic Acid SCHEMBL1871339 | 0.88 | EGLN1 (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL2761469 | 0.85 | TSHR (0.48) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL5158691 | 0.85 | LMNA (0.46) | ALDH1A1TSHRCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240173283-A1 | PROPHYLACTIC AGENT OR THERAPEUTIC AGENT FOR SIDE EFFECTS OF ANTHRACYCLINE ANTICANCER AGENT | SBI PHARMACEUTICALS CO., LTD. (JP) | 2024-05-30 | — | — | US | claimed |
| EP-4316480-A1 | PROPHYLACTIC AGENT OR THERAPEUTIC AGENT FOR SIDE EFFECTS OF ANTHRACYCLINE ANTICANCER AGENT | Kyushu University, National University Corporation (JP) | 2024-02-07 | — | — | EP | claimed |
| US-4362710-A | Feeds for baby pigs, process for preparing the same and method of breeding baby pigs | NISSAN GOSEI KOGYO CO., LTD. (JP) | 1982-12-07 | — | — | US | claimed |
| US-20240173283-A1 | PROPHYLACTIC AGENT OR THERAPEUTIC AGENT FOR SIDE EFFECTS OF ANTHRACYCLINE ANTICANCER AGENT | SBI PHARMACEUTICALS CO., LTD. (JP) | 2024-05-30 | — | — | US | disclosed |
| EP-4316480-A1 | PROPHYLACTIC AGENT OR THERAPEUTIC AGENT FOR SIDE EFFECTS OF ANTHRACYCLINE ANTICANCER AGENT | Kyushu University, National University Corporation (JP) | 2024-02-07 | — | — | EP | disclosed |
| US-11633505-B2 | Nuclear magnetic resonance diagnostic agent, and method for detecting or diagnosing state of cell, tissue or organ in subject using same | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2023-04-25 | — | — | US | disclosed |
| WO-2022215655-A1 | LIVESTOCK FEED | 住友化学株式会社 | 2022-10-13 | — | — | WO | disclosed |
| WO-2022202477-A1 | PROPHYLACTIC AGENT OR THERAPEUTIC AGENT FOR SIDE EFFECTS OF ANTHRACYCLINE ANTICANCER AGENT | 国立大学法人九州大学 | 2022-09-29 | — | — | WO | disclosed |
| WO-2022176904-A1 | LIVESTOCK FEED | 住友化学株式会社 | 2022-08-25 | — | — | WO | disclosed |
| WO-2022176902-A1 | LIVESTOCK FEED | 住友化学株式会社 | 2022-08-25 | — | — | WO | disclosed |
| WO-2022176903-A1 | LIVESTOCK FEED | 住友化学株式会社 | 2022-08-25 | — | — | WO | disclosed |
| WO-2022131287-A1 | LIVESTOCK FEED | 住友化学株式会社 | 2022-06-23 | — | — | WO | disclosed |
| WO-2022131288-A1 | ABSCISIC ACID-MIXED PIG FEED | 住友化学株式会社 | 2022-06-23 | — | — | WO | disclosed |
| WO-2021215517-A1 | THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CORONAVIRUS DISEASE 2019 (COVID-19) | ネオファーマジャパン株式会社 (JP) | 2021-10-28 | — | — | WO | disclosed |
| WO-2021132626-A1 | THERAPEUTIC AND/OR PREVENTIVE AGENT FOR CLASSICAL SWINE FEVER | 国立大学法人北海道大学 | 2021-07-01 | — | — | WO | disclosed |
| WO-2021054473-A1 | AGENT FOR AMELIORATING AND/OR PREVENTING SICKLE CELL DISEASE | 国立大学法人 東京大学 | 2021-03-25 | — | — | WO | disclosed |
| CN-104487066-B | Prophylactic and/or therapeutic agent for radiation damage | 国立大学法人东京大学 | 2020-06-09 | — | — | CN | disclosed |
| EP-2932983-B1 | NUCLEAR MAGNETIC RESONANCE DIAGNOSTIC AGENT, AND USE THEREOF IN A METHOD FOR DETECTING OR DIAGNOSING STATE OF CELL, TISSUE OR ORGAN IN SUBJECT | UNIV KUMAMOTO NAT UNIV CORP (JP) | 2018-09-12 | — | — | EP | disclosed |
| US-20150320888-A1 | NUCLEAR MAGNETIC RESONANCE DIAGNOSTIC AGENT, AND METHOD FOR DETECTING OR DIAGNOSING STATE OF CELL, TISSUE OR ORGAN IN SUBJECT USING SAME | UNIV KUMAMOTO NAT UNIV CORP (JP) | 2015-11-12 | — | — | US | disclosed |
| EP-2932983-A1 | NUCLEAR MAGNETIC RESONANCE DIAGNOSTIC AGENT, AND METHOD FOR DETECTING OR DIAGNOSING STATE OF CELL, TISSUE OR ORGAN IN SUBJECT USING SAME | National University Corporation Kumamoto University (JP) | 2015-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150320888-A1 | NUCLEAR MAGNETIC RESONANCE DIAGNOSTIC AGENT, AND METHOD FOR DETECTING OR DIAGNOSING STATE OF CELL, TISSUE OR ORGAN IN SUBJECT USING SAME | GOT1, GOT2, AADAT | ALDH1A1 1304/4885TSHR 3477/4885CYP2D6 1689/4885 |
| US-11633505-B2 | Nuclear magnetic resonance diagnostic agent, and method for detecting or diagnosing state of cell, tissue or organ in subject using same | GOT1, GOT2, AADAT | ALDH1A1 1304/4885TSHR 3477/4885CYP2D6 1689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.